Shanghai OPM Biosciences Co Ltd
SSE:688293
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Deutsche Biotech Innovativ AG
XETRA:DBI
|
DE |
|
Cinderson Tech Suzhou Co Ltd
SSE:603344
|
CN |
Shanghai OPM Biosciences Co Ltd
Inventory
Shanghai OPM Biosciences Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shanghai OPM Biosciences Co Ltd
SSE:688293
|
Inventory
¥59m
|
CAGR 3-Years
21%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Inventory
¥3.6B
|
CAGR 3-Years
32%
|
CAGR 5-Years
78%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Inventory
¥1.3B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Inventory
¥661.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Inventory
¥931.6m
|
CAGR 3-Years
40%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Inventory
¥63m
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shanghai OPM Biosciences Co Ltd
Glance View
Shanghai OPM Biosciences Co. Ltd. engages in the cell culture products and services. The company is headquartered in Shanghai, Shanghai and currently employs 261 full-time employees. The company went IPO on 2022-09-02. The firm's cell culture medium products are widely used in the manufacturing of protein, antibiotics, vaccine, cell therapy products, gene therapy products, and other biological products. The firm's contract development and manufacturing organization (CDMO) service platform provides comprehensive services covering antibody engineering humanized screening, cell strain cultivation, process development, pilot scale production, and clinical-stage sample production. The firm conducts businesses both in the domestic market and overseas markets.
See Also
What is Shanghai OPM Biosciences Co Ltd's Inventory?
Inventory
59m
CNY
Based on the financial report for Dec 31, 2024, Shanghai OPM Biosciences Co Ltd's Inventory amounts to 59m CNY.
What is Shanghai OPM Biosciences Co Ltd's Inventory growth rate?
Inventory CAGR 5Y
30%
Over the last year, the Inventory growth was 20%. The average annual Inventory growth rates for Shanghai OPM Biosciences Co Ltd have been 21% over the past three years , 30% over the past five years .
